Stock-Based Compensation (Details 1) |
12 Months Ended |
---|---|
Dec. 31, 2020
USD ($)
$ / shares
shares
| |
Number Outstanding | 4,278,619 |
Number Exercisable | 3,448,619 |
Warrants [Member] | |
Number Outstanding | 175,000 |
Number Exercisable | 125,000 |
Proceeds to Company if Exercised | $ | $ 481,250 |
Warrant One [Member] | |
Number Outstanding | 125,000 |
Number Exercisable | 125,000 |
Proceeds to Company if Exercised | $ | $ 308,750 |
Exercise Price | $ / shares | $ 2.47 |
Weighted Average Remaining Contractual Life (Years) | 2 years 1 month 24 days |
Warrant Two [Member] | |
Number Outstanding | 50,000 |
Number Exercisable | 0 |
Proceeds to Company if Exercised | $ | $ 172,500 |
Exercise Price | $ / shares | $ 3.45 |
Weighted Average Remaining Contractual Life (Years) | 5 years 2 months 1 day |
X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|